COVID-19 Request Received
Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.
We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!
Your source for all things biotech
Stay informed with our expert insights, industry news, and groundbreaking discoveries.
Kancera credits new drug with slowing pancreatic cancer tumor growth
From the FierceBiotech Article: Swedish drug developer Kancera says it has slowed the growth of pancreatic cancer tumors in preclinical...
Amgen enzyme combats obesity, diabetes in monkeys
Amgen (AMGN) has an interesting new weapon in the battle againstobesity. The company's scientists successfully used an antibody they discovered...
Stem cell-reliant HIV vaccine launches animal studies in January
Scientists at the Texas Biomedical Research Institute have big plans for a new treatment designed to help stop the transmission...
Roche to release Tamiflu data
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure...
McGill scientists link autistic behavior to brain protein mutation
McGill Universityresearchers and colleagues discovered a protein abnormality linked to symptoms ofautismin mice. Interestingly, as Bloomberg reports, the scientists were...
